Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altmann, M. and Hammerschmidt, W. (2005) Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol. 3, 2148–2157.
Arrand, J.R. and Rymo, L. (1982) Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J. Virol. 41, 376–389.
Arrand, J.R., Young, L.S. and Tugwood, J.D. (1989) Two families of sequences in the small RNA-encoding region of Epstein- Barr virus (EBV) correlate with EBV types A and B. J. Virol. 63, 983–986.
Austin, P.J., Flemington, E., Yandava, C.N., Strominger, J.L. and Speck, S.H. (1988) Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes. Proc. Natl. Acad. Sci. USA 85, 3678–3682.
Baer, R., Bankier, A.T., Biggin, M.D., Deininger, P.L., Farrell, P.J., Gibson, T.J., Hatfull, G., Hudson, G.S., Satchwell, S.C., Seguin, C., Tuffnell, P.S. and Barrell, B.G. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207–211.
Cai, X., Schafer, A., Lu, S., Bilello, J.P., Desrosiers, R.C., Edwards, R., Raab-Traub, N. and Cullen, B.R. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2, 236–247.
Chaudhuri, B., Xu, H., Todorov, I., Dutta, A. and Yates, J.L. (2001) Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 98, 10085–10089.
Chen, H., Smith, P., Ambinder, R.F. and Hayward, S.D. (1999) Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. Blood 93, 3026–3032.
Chen, H.L., Lung, M.M., Sham, J.S., Choy, D.T., Griffin, B.E. and Ng, M.H. (1992) Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology 191, 193–201.
Cohen, J.I., Wang, F., Mannick, J. and Kieff, E. (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86, 9558–9562.
Dalbies-Tran, ,R., Stigger-Rosser, E., Dotson, T. and Sample, C.E. (2001) Amino acids of Epstein-Barr virus nuclear antigen 3A essential for repression of Jκ-mediated transcription and their evolutionary conservation. J. Virol. 75, 90–99.
Dambaugh, T., Hennessy, K., Chamnankit, L. and Kieff, E. (1984) U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. USA 81, 7632–7636.
de Jesus, O., Smith, P.R., Spender, L.C., Elgueta Karstegl, C., Niller, H.H., Huang, D. and Farrell, P.J. (2003) Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J. Gen. Virol. 84, 1443–1450.
Deng, Z., Lezina, L., Chen, C.J., Shtivelband, S., So, W. and Lieberman, P.M. (2002) Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Mol. Cell 9, 493–503.
Dhar, S.K., Yoshida, K., Machida, Y., Khaira, P., Chaudhuri, B., Wohlschlegel, J.A., Leffak, M., Yates, J. and Dutta, A. (2001) Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell 106, 287–296.
Dolan, A., Addison, C., Gatherer, D., Davison, A.J. and McGeoch, D.J. (2006) The genome of Epstein-Barr virus type 2 strain AG876. Virology 350, 164–170.
Fennewald, S., Van Santen, V. and Kieff, E. (1984) Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol. 51, 411–419.
Glickman, J.N., Howe, J.G. and Steitz, J.A. (1988) Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J. Virol. 62, 902–911.
Hammerschmidt, W. and Sugden, B. (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393–397.
Howe, J.G. and Shu, M.D. (1989) Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements. Cell 57, 825–834.
Jiang, H., Cho, Y. and Wang, F. (2000) Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus. J. Virol. 74, 5921–5932.
Kapoor, P., Lavoie, B.D. and Frappier, L. (2005) EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases. Mol. Cell. Biol. 25, 4934–4945.
Kelly, G., Bell, A. and Rickinson, A. (2002) Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat. Med. 8, 1098–1104.
Kelly, G.L., Milner, A.E., Tierney, R.J., Croom-Carter, D.S.G., Altmann, M., Hammerschmidt, W., Bell, A.I. and Rickinson, A.B. (2005) Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA-3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J. Virol. 79, 10709–10717.
Komano, J., Maruo, S., Kurozumi, K., Oda, T. and Takada, K. (1999) Oncogenic role of Epstein-Barr virus-encoded RNA in Burkitt's lymphoma cell line Akata. J. Virol. 73, 9827–9831.
Laux, G., Economou, A. and Farrell, P.J. (1989) The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region. J. Gen. Virol. 70, 3079–3084.
Laux, G., Perricaudet, M. and Farrell, P.J. (1988) A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO J. 7, 769–774.
Nonkwelo, C., Skinner, J., Bell, A., Rickinson, A. and Sample, J. (1996) Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J. Virol. 70, 623–627.
Parker, B.D., Bankier, A., Satchwell, S., Barrell, B. and Farrell, P.J. (1990) Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179, 339–346.
Pearson, G.R., Luka, J., Petti, L., Sample, J., Birkenbach, M., Braun, D. and Kieff, E. (1987) Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160, 151–161.
Pfeffer, S., Zavolan, M., Grasser, F.A., Chien, M., Russo, J.J., Ju, J., John, B., Enright, A.J., Marks, D., Sander, C. and Tuschl, T. (2004) Identification of virus-encoded microRNAs. Science 304, 734–736.
Raab-Traub, N., Dambaugh, T. and Kieff, E. (1980) DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell 22, 257–267.
Rickinson, A.B., Young, L.S. and Rowe, M. (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA2 on the growth phenotype of virus-transformed B cells. J. Virol. 61, 1310–1317.
Rivailler, P., Cho, Y.G. and Wang, F. (2005) Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a New World primate: a defining point in the evolution of oncogenic lymphocryptoviruses. J. Virol. 76, 12055–12068.
Rivailler, P., Jiang, H., Cho, Y.G., Quink, C. and Wang, F. (2002) Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model. J. Virol. 76, 421–426.
Rogers, R.P., Woisetschlaeger, M. and Speck, S.H. (1990) Alternative splicing dictates translational start in Epstein-Barr virus transcripts. EMBO J. 9, 2273–2277.
Rooney, C.M., Brimmell, M., Buschle, M., Allan, G., Farrell, P.J. and Kolman, J.L. (1992) Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. J. Virol. 66, 496–504.
Rowe, M., Young, L.S., Cadwallader, K., Petti, L., Kieff, E. and Rickinson, A.B. (1989) Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J. Virol. 63, 1031–1039.
Ruf, I.K., Rhyne, P.W., Yang, C., Cleveland, J.L. and Sample, J.T. (2000) Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J. Virol. 74, 10223–10228.
Sadler, R.H. and Raab-Traub, N. (1995) Structural analyses of the Epstein-Barr virus BamHI A transcripts. J. Virol. 69, 1132–1141.
Sample, J., Hummel, M., Braun, D., Birkenbach, M. and Kieff, E. (1986) Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc. Natl. Acad. Sci. USA 83, 5096–5100.
Sample, J., Liebowitz, D. and Kieff, E. (1989) Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J. Virol. 63, 933–937.
Sample, J., Young, L., Martin, B., Chatman, T., Kieff, E. and Rickinson, A. (1990) Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64, 4084–4092.
Schaefer, B.C., Strominger, J.L. and Speck, S.H. (1995) Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA 92, 10565–10569.
Schepers, A., Ritzi, M., Bousset, K., Kremmer, E., Yates, J.L., Harwood, J., Diffley, J.F. and Hammerschmidt, W. (2001) Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J. 20, 4588–4602.
Sears, J., Ujihara, M., Wong, S., Ott, C., Middeldorp, J. and Aiyar, A. (2004) The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J. Virol. 78, 11487–11505.
Shire, K., Ceccarelli, D.F., Avolio-Hunter, T.M. and Frappier, L. (1999) EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J. Virol. 73, 2587–2595.
Skare, J., Farley, J., Strominger, J.L., Fresen, K.O., Cho, M.S. and zur Hausen, H. (1985) Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H. J. Virol. 55, 286–297.
Smith, P.R., de Jesus, O., Turner, D., Hollyoake, M., Karstegl, C.E., Griffin, B.E., Karran, L., Wang, Y., Hayward, S.D. and Farrell, P.J. (2000) Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J. Virol. 74, 3082–3092.
Speck, S.H., Pfitzner, A. and Strominger, J.L. (1986) An Epstein-Barr virus transcript from a latently infected, growth- transformed B-cell line encodes a highly repetitive polypeptide. Proc. Natl. Acad. Sci. USA 83, 9298–9302.
Tierney, R., Nagra, J., Hutchings, I., Shannon-Lowe, C., Altmann, M., Hammerschmidt, W., Rickinson, A. and Bell, A. (2007) Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program. J. Virol. 81, 10092–10100.
Tsurumi, T., Fujita, M. and Kudoh, A. (2005) Latent and lytic Epstein-Barr virus replication strategies. Rev. Med. Virol. 15, 3–15.
Woisetschlaeger, M., Jin, X.W., Yandava, C.N., Furmanski, L.A., Strominger, J.L. and Speck, S.H. (1991) Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Proc. Natl. Acad. Sci. USA 88, 3942–3946.
Woisetschlaeger, M., Yandava, C.N., Furmanski, L.A., Strominger, J.L. and Speck, S.H. (1990) Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl. Acad. Sci. USA 87, 1725–1729.
Wu, Y., Maruo, S., Yajima, M., Kanda, T. and Takada, K. (2007) Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. J. Virol. 81, 11236–11245.
Yajima, M., Kanda, T. and Takada, K. (2005) Critical role of Epstein-Barr virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. J. Virol. 79, 4298–4307.
Yao, Q.Y., Croom-Carter, D.S., Tierney, R.J., Habeshaw, G., Wilde, J.T., Hill, F.G., Conlon, C. and Rickinson, A.B. (1998) Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort. J. Virol. 72, 4352–4363.
Yoo, L.I., Mooney, M., Puglielli, M.T. and Speck, S.H. (1997) B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP- proximal EBNA gene promoter Wp1. J. Virol. 71, 9134–9142.
Young, L.S., Yao, Q.Y., Rooney, C.M., Sculley, T.B., Moss, D.J., Rupani, H., Laux, G., Bornkamm, G.W. and Rickinson, A.B. (1987) New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J. Gen. Virol 68, 2853–2862.
Zeng, M.S., Li, D.J., Liu, Q.L., Song, L.B., Li, M.Z., Zhang, R.H., Yu, X.J., Wang, H.M., Ernberg, I. and Zeng, Y.X. (2005) Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J. Virol. 79, 15323–15330.
Zhao, B., Dalbies-Tran, R., Jiang, H., Ruf, I.K., Sample, J.T., Wang, F. and Sample, C.E. (2003) Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses. J. Virol. 77, 5639–5648.
Zimber, U., Adldinger, H.K., Lenoir, G.M., Vuillaume, M., Knebel-Doeberitz, M.V., Laux, G., Desgranges, C., Wittmann, P., Freese, U.K., Schneider, U. and Bornkamm, G. (1986) Geographical prevalence of two types of Epstein-Barr virus. Virology 154, 56–66.
Zimmermann, J. and Hammerschmidt, W. (1995) Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA. J. Virol. 69, 3147–3155.
Acknowledgments
Much of the material presented in Fig. 11.2 and Table 11.1 was adopted from information available at http://www.med.ic.ac.uk/ludwig/ebv.htm that is maintained by Dr. Paul Farrell. We apologize to our many colleagues whose work could not be fully cited due to space constraints. We gratefully acknowledge our research support from U.S. Public Health Service grants CA056639 and CA073544 (to J.T.S.), CA056645 and CA117827 (to C.E.S.), and the Penn State Hershey Cancer Institute.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Sample, J.T., Marendy, E.M., Hughes, D.J., Sample, C.E. (2009). The Epstein–Barr Virus Genome. In: Damania, B., Pipas, J.M. (eds) DNA Tumor Viruses. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68945-6_11
Download citation
DOI: https://doi.org/10.1007/978-0-387-68945-6_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-68944-9
Online ISBN: 978-0-387-68945-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)